The Effects of Two Endometrium Preparation Protocols in Frozen-thawed Embryo Transfer in Women With Irregular Cycles

Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (Other)
Overall Status
Unknown status
CT.gov ID
NCT01780610
Collaborator
(none)
670
1
2
36
18.6

Study Details

Study Description

Brief Summary

There are two main cycle regimens used for endometrial preparation for frozen embryo transfer (FET) in women with irregular cycles: hormone replacement therapy cycles (HRT) in which the endometrium is artificially prepared by estrogen and progesterone hormones with/without a gonadotrophin releasing hormone agonist (GnRH-a) down regulation, and ovulation induced cycles (OI) in which follicular development is supported with increasing doses of gonadotrophin hormones and ovulation is induced. At present, there is still no sufficient evidence that which kind of frozen embryo transfer cycle regimen to plan more advantage. The purpose of this study was to compare the pregnancy outcome of hormone replacement therapy cycles (HRT) and ovulation induced cycles (OI) in women with irregular cycles.

Condition or Disease Intervention/Treatment Phase
  • Drug: Letrozole and human chorionic gonadotrophin
  • Drug: estradiol and progesterone
N/A

Detailed Description

This study is a prospective randomized controlled trial. Patients with irregular cycles undergoing FET in reproductive medicine renter of Sun Yat-sen Memorial Hospital will be recruited who should not be elder than 40 and had more than 3 frozen embryos. They will be randomized to receive either the OI-FET cycle (group OI-A) or the HRT-FET cycle (group HRT-B). In group OI-A, the follicular development is supported by Letrozole(LE) 2.5mg,once daily,is introduced on cycle day 3 .And on cycle day 10 , a Vagina ultrasound is introduced to monitor the development of the follicular ,following by intramuscular gonadotrophin 37.5~75 IU/d until there is a Luteinizing Hormone(LH) surge or ovulation .On the day appearing Luteinizing Hormone surge,patient is always introduced intramuscular human chorionic gonadotrophin(HCG) 10000 IU.If there is sill no Luteinizing Hormone surge when the follicle is 20-24mm ,the ovulation will be induced by HCG.Then the luteum is supported by HCG 2000-2500 IU/3d.Transfer of thawed embryos will be performed 3 days after ovulation is observed. In group HRT-B, oral estradiol, 2 mg, once daily, is introduced on cycle day 3 with an increasing doses protocol. If the endometrial thickness is greater than 7mm, progesterone 40-60 mg in oil will be administered via intramuscular injection. Transfer of thawed embryos will be performed 3 days later.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
670 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
The Effects of Two Endometrium Preparation Protocols in Frozen-thawed Embryo Transfer in Women With Irregular Cycles
Study Start Date :
Jan 1, 2012
Anticipated Primary Completion Date :
Jan 1, 2015
Anticipated Study Completion Date :
Jan 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Other: group OI-A

Patients with irregular cycles undergoing FET in reproductive medicine renter of Sun Yat-sen Memorial Hospital will be recruited , who should not be elder than 40 and had more than 3 frozen embryos.They will be randomized to receive the Letrozole and human chorionic gonadotrophin ovulation induced cycles.

Drug: Letrozole and human chorionic gonadotrophin
the follicular development is supported by Letrozole(LE) 2.5mg,once daily is introduced on cycle day 3 .And on cycle day 10 , a Vagina ultrasound is introduced to monitor the development of the follicular ,following by intramuscular gonadotrophin 37.5~75 IU/d until there is a Luteinizing Hormone(LH) surge or ovulation .On the day appearing Luteinizing Hormone surge,patients is always introduced intramuscular human chorionic gonadotrophin(HCG) 10000 IU.If there is sill no Luteinizing Hormone surge when the follicle is 20-24mm ,the ovulation will be induced by HCG.Then the luteum was supported by HCG 2000-2500 IU/3d.Transfer of thawed embryos will be performed 3 days after ovulation is observed.
Other Names:
  • Letrozole tablets
  • HCG
  • Chorionic gonadotrophin
  • Chorionic gonadotropic hormone
  • Other: group HRT-B

    Patients with irregular cycles undergoing FET in reproductive medicine renter of Sun Yat-sen Memorial Hospital will be recruited, who should not be elder than 40 and had more than 3 frozen embryos will be randomized to receive the estradiol and progesterone replacement therapy cycles.

    Drug: estradiol and progesterone
    oral estradiol, 2 mg, once daily, was introduced on cycle day 3 with an increasing doses protocol. If the endometrial thickness was greater than 7mm, progesterone 40-60 mg in oil was administered via intramuscular injection. Transfer of thawed embryos was performed 3 days later
    Other Names:
  • Estradiol Valerate
  • Progynova
  • 3,20-pregnene-4; 4-pregnene-3,20-dione
  • corpus luteum hormone
  • luteal hormone
  • Outcome Measures

    Primary Outcome Measures

    1. ongoing pregnancy rate [12 weeks after pregnancy]

      12 weeks after pregnancy,people go Vaginal B ultrasonic examination,being saw gestational sac and heart tube beat as ongoing pregnancy

    Secondary Outcome Measures

    1. pregnancy rate [2 weeks after Embryo transplantation]

      2 weeks after Embryo transplantation, people go urine HCG and blood HCG test,positive as pregnancy

    2. clinical pregnancy rate [5 weeks after Embryo transplantation]

      5 weeks after Embryo transplantation,people go Vaginal B ultrasonic,being saw the gestation sac as clinical pregnancy

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 40 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Age forty years old or less

    • Has irregular Menstruation (cycle more than 35 days or less than 24 days ) or has regulation Menstruation but previous data suggest that abnormal ovulation

    • Frozen embryos number more than three

    Exclusion Criteria:
    • Has Chocolate cyst or adenomyosis of uterus

    • Clear hydrosalpinx

    • Uterine scar or intrauterine adhesion and endometrial thickness <7mm before ovulation

    • recur thick endometrium(<7mm)

    • repeated implantation failure(≥3 times)

    • Cancel the cycle because of having no dominant follicle in the ovulation induction(OI)+FET before or the growth of endometrium not good in the HRT+FET before

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sun Yat-Sen Memorial Hospital Guangzhou Guangdong China 510000

    Sponsors and Collaborators

    • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    Investigators

    • Study Director: Zhang qingxue, doctor, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Qingxue Zhang, professor, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
    ClinicalTrials.gov Identifier:
    NCT01780610
    Other Study ID Numbers:
    • SunYatsenU2H- QZhang
    First Posted:
    Jan 31, 2013
    Last Update Posted:
    Apr 2, 2013
    Last Verified:
    Mar 1, 2013

    Study Results

    No Results Posted as of Apr 2, 2013